Literature DB >> 3384218

Serum lipids and apolipoproteins in children with type 1 (insulin-dependent) diabetes during the first two years of the disease.

M Kobbah1, B Vessby, T Tuvemo.   

Abstract

Serum lipoproteins and apolipoproteins were studied at diagnosis and 6, 12 and 24 months later in 30 consecutive children aged 3-15 years with newly detected Type 1 (insulin-dependent) diabetes mellitus (December 1982-October 1984) and in 44 healthy control children. Serum triglycerides at diagnosis were significantly higher than after 6-24 months and also higher than in the control group (p less than 0.001). At follow-up, triglycerides in the very low density lipoproteins and low density lipoproteins were restored to normal, while high density lipoprotein triglycerides remained high. Serum cholesterol at onset of diabetes was significantly higher than in the control children (p less than 0.01), mainly because of increased very low density lipoprotein cholesterol (p less than 0.001). Cholesterol in serum and in the serum lipoprotein fractions was similar to that in the control children at follow-up, except that high density lipoprotein cholesterol was higher in the diabetic children after 6 months. The concentrations of the serum apolipoproteins A-I, A-II and B were higher at onset of diabetes than in the control children (p less than 0.001, p less than 0.01, p less than 0.05 respectively), with a significantly increased ratio of apolipoprotein A-I to A-II in the diabetic children (p less than 0.001). The serum apolipoprotein concentrations were normalised during treatment. The ratio of apolipoprotein A-I to B did not differ from that in control children. On admission, there were strong positive correlations between HbA1c and the concentrations of the very low density lipoproteins and the low density and high density lipoprotein triglycerides.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384218     DOI: 10.1007/bf00290584

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Metabolic control, glycosylated haemoglobin and high density lipoprotein cholesterol in diabetic children.

Authors:  L Klujber; D Molnár; M Kardos; V Jászai; G Soltész; J Mestyán
Journal:  Eur J Pediatr       Date:  1979       Impact factor: 3.183

2.  The effect of continuous subcutaneous insulin infusion on serum lipids.

Authors:  P Lawson; I Trayner; J Rosenstock; E Kohner
Journal:  Diabete Metab       Date:  1984-10

Review 3.  High-density lipoprotein metabolism.

Authors:  A Nicoll; N E Miller; B Lewis
Journal:  Adv Lipid Res       Date:  1980

4.  Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus.

Authors:  F L Dunn; A Pietri; P Raskin
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

5.  Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control.

Authors:  M F Lopes-Virella; H J Wohltmann; C B Loadholt; M G Buse
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

6.  Separation of serum high-density lipoprotein for cholesterol determination: ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride.

Authors:  L Seigler; W T Wu
Journal:  Clin Chem       Date:  1981-06       Impact factor: 8.327

7.  Human intestinal lipoproteins. Studies in chyluric subjects.

Authors:  P H Green; R M Glickman; C D Saudek; C B Blum; A R Tall
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

8.  Serum apolipoproteins A-I, A-II and B in diabetic children and matched healthy controls.

Authors:  U Ewald; T Tuvemo; B Vessby; O Wålinder
Journal:  Acta Paediatr Scand       Date:  1982-01

9.  High density lipoprotein composition in insulin-dependent diabetes mellitus.

Authors:  R H Eckel; J J Albers; M C Cheung; P W Wahl; F T Lindgren; E L Bierman
Journal:  Diabetes       Date:  1981-02       Impact factor: 9.461

10.  Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump.

Authors:  J M Falko; T M O'Dorisio; S Cataland
Journal:  JAMA       Date:  1982-01-01       Impact factor: 56.272

View more
  5 in total

Review 1.  Lipoprotein alterations in diabetes mellitus.

Authors:  G M Kostner; I Karádi
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

Review 2.  Triglycerides and disease.

Authors:  C A Seymour; C D Byrne
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

3.  Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study.

Authors:  Aleksandra Cieluch; Aleksandra Uruska; Marcin Nowicki; Ewa Wysocka; Paweł Niedźwiecki; Agata Grzelka-Woźniak; Justyna Flotyńska; Dorota Zozulińska-Ziółkiewicz
Journal:  Arch Med Sci       Date:  2020-10-29       Impact factor: 3.707

4.  Platelet aggregability during the first two years of type 1 (insulin-dependent) diabetes mellitus in children.

Authors:  A M Kobbah; U Ewald; T Tuvemo
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

5.  Circulating lipids and glycaemic control in insulin dependent diabetic children.

Authors:  K Azad; J M Parkin; S Court; M F Laker; K G Alberti
Journal:  Arch Dis Child       Date:  1994-08       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.